Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Urinary Retention × Tamsulosin × Clear all

Phase

Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Retention 1 Lung Neoplasms 1

Interventions

Tranexamic Acid 1 Tamsulosin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03609580 2025-10-24

POUR

Hackensack Meridian Health

Phase 1/2 Recruiting

Lung Neoplasms, Urinary Retention

Data powered by HemOnc (CC BY 4.0) Colophon ⚡